Osteomyelitis — infection of bone — in the foot and ankle is a serious, limb-threatening condition that requires prompt diagnosis and aggressive treatment. It most commonly develops as a complication of diabetic foot ulcers, puncture wounds, or post-surgical infection, and is the leading cause of foot and ankle amputation when inadequately treated. At Balance Foot & Ankle, Dr. Tom Biernacki, DPM diagnoses and manages foot osteomyelitis including surgical debridement and limb salvage in Howell and Bloomfield Hills, Michigan. Call (810) 206-1402 urgently if you have an infected diabetic foot wound.

Quick Answer: What Is Osteomyelitis?

Osteomyelitis is bacterial (occasionally fungal) infection of bone — most commonly Staphylococcus aureus (including MRSA), Streptococcus species, and gram-negative organisms in diabetic foot infections. In the foot, osteomyelitis most commonly develops by contiguous spread from an overlying wound (the diabetic foot ulcer route) rather than hematogenous seeding. The infection produces progressive bone destruction — cortical erosion, medullary cavity infection, and eventually pathological fracture or bone devitalization (sequestrum). The infected devitalized bone (sequestrum) must be surgically removed for antibiotic therapy to work — antibiotics cannot penetrate avascular necrotic bone.

Recognizing Osteomyelitis in Diabetic Foot Wounds

The most important clinical test is the “probe to bone” test: when a sterile metal probe or cotton swab is inserted into a diabetic foot ulcer and bone is contacted, the positive predictive value for underlying osteomyelitis is approximately 89%. A positive probe-to-bone test mandates immediate osteomyelitis workup. Laboratory findings: elevated ESR (>70 mm/hr has 89% specificity for osteomyelitis in diabetic foot), elevated CRP, elevated WBC in systemic infection (WBC may be normal in chronic, indolent osteomyelitis). Plain radiographs show bone erosion, periosteal reaction, and cortical loss — but these changes lag the clinical infection by 10–21 days and may be absent in early osteomyelitis. MRI is the gold standard imaging — bone marrow edema with cortical destruction is 90%+ sensitive and specific for osteomyelitis; positive before radiographic changes appear.

Treatment: Medical vs. Surgical

Medical management alone is appropriate for: superficial osteomyelitis without cortical destruction, cases in patients who are not surgical candidates, and cases where infection is limited to small, non-weight-bearing bones (phalanges). Protocol: 4–6 weeks of IV antibiotics guided by bone culture and sensitivities, followed by oral antibiotic step-down based on response. Medical failure rate: 30–40% — many patients treated medically for osteomyelitis in the foot have recurrence.

Surgical debridement is indicated for: probe-to-bone positive wounds with cortical involvement; failed antibiotic therapy; systemic sepsis from foot source; necrotic or devitalized bone; and chronic osteomyelitis with sequestrum formation. Surgical principles: complete debridement to bleeding bone margins (the “paprika sign” — visible bleeding from cancellous bone confirms viable tissue); preservation of the remaining viable foot architecture; filling the debridement cavity with antibiotic-impregnated cement spacer or bioactive glass when large defects exist; wound closure with flap rotation or negative pressure wound therapy (NPWT); and post-operative IV antibiotics for 4–6 weeks.

Amputation level decisions: When osteomyelitis is too extensive for viable limb salvage, the goal is the most distal amputation that achieves healing — preserving as much functional tissue as possible. Partial foot amputations (ray resection, transmetatarsal amputation, Chopart amputation) are performed when feasible. Below-knee amputation is considered when infection involves the hindfoot or ankle with inadequate remaining blood supply to heal a more distal level.

Bone Culture: Essential for Treatment

Antibiotic therapy for osteomyelitis should be guided by bone culture, not wound swab culture. Wound swab cultures from diabetic foot ulcers are frequently contaminated with colonizing organisms that do not reflect the true bone pathogen. Bone biopsy (preferably via surgical approach, or CT-guided percutaneous biopsy) provides the definitive culture specimen. MRSA is present in 20–30% of diabetic foot osteomyelitis cases — empiric vancomycin coverage should be included while awaiting culture results in high-risk patients.

Most Common Mistake with Foot Osteomyelitis

The most common mistake: treating diabetic foot osteomyelitis with oral antibiotics only based on wound swab culture, without surgical debridement or bone biopsy. In our clinic, we see this pattern regularly — patients treated for weeks to months with oral antibiotics prescribed by primary care for a wound culture — when the actual bone pathogen is different, the antibiotic spectrum is wrong, or there’s devitalized bone present that antibiotics cannot penetrate. A diabetic foot wound with bone contact or radiographic bone erosion is a surgical emergency requiring podiatric and infectious disease co-management — not outpatient antibiotic management alone. Call (810) 206-1402 urgently if you have a diabetic foot wound that has failed antibiotic treatment, is worsening, or reaches bone.